Non Hodgkin's Lymphoma
Cyberfamily
Drugs in the Pipeline
Lest there be any doubt that there is enough research being done to cure non-hodgkin's lymphoma, let us look at a list of drugs that are currently in some stage of development or clinical trials. Most of these are in Phase II or III trials. While some of them may never make it to market, it is clear that those of us with NHL have many options available and the future holds a lot of promise.
We make no attempt to explain what any of these treatments are, merely to list them and attempt to keep the list updated. A search at Google or any other search engine will find you more information about most of them. Better still search the American Society of Hematology annual meeting abstracts for even more specific information.
Epratuzumab
Lymphocide (Epratuzumab with Y90)
Campath (Alemtuzumab)
SDX-105 (bendamustine) Brand name TREANDA(TM)
IDEC-114
Doxil (Liposomal Doxorubicin)
Marqibo (Liposomal Vincristine)
Genasense
1D09C3
HuMax-CD20
Nipent (Pentostatin)
PT-100
Dendritic cell vaccine
Heat Shock Vaccine
FavID (Favrille vaccine)
Velcade (Bortezomib )
Ganite (Galium Nitrate)
MyVax (GTOP-99)
Gemcitabine (brand name Gemzar)
Remitogen (ID-10)
Lymphorad
Bexarotene Gel
tezacitabine
GTI-2040
BL-22
ONTAK (DENILEUKIN DIFTITOX)
ATRAGEN (Liposomal Tretinoin)
MDX-060
HEFI-1
SGN-30
Xcytrin(R) (motexafin gadolinium)For an even more comprehensive list of products in the pipeline for treating all manner of haematological malignancies, the Hemonc Today web site has a brochure you can download.
Download the 2006 drug pipeline brochure here
© 2006 NHL Cyberfamily All Rights Reserved.
Web design by Long2 Consulting